CHLOROTHIAZIDE-RESERPINE Drug Patent Profile
✉ Email this page to a colleague
When do Chlorothiazide-reserpine patents expire, and what generic alternatives are available?
Chlorothiazide-reserpine is a drug marketed by Norvium Bioscience and is included in two NDAs.
The generic ingredient in CHLOROTHIAZIDE-RESERPINE is chlorothiazide; reserpine. There are forty-two drug master file entries for this compound. Additional details are available on the chlorothiazide; reserpine profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CHLOROTHIAZIDE-RESERPINE?
- What are the global sales for CHLOROTHIAZIDE-RESERPINE?
- What is Average Wholesale Price for CHLOROTHIAZIDE-RESERPINE?
Summary for CHLOROTHIAZIDE-RESERPINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Patent Applications: | 2 |
| DailyMed Link: | CHLOROTHIAZIDE-RESERPINE at DailyMed |
US Patents and Regulatory Information for CHLOROTHIAZIDE-RESERPINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Norvium Bioscience | CHLOROTHIAZIDE-RESERPINE | chlorothiazide; reserpine | TABLET;ORAL | 087744-001 | May 6, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Norvium Bioscience | CHLOROTHIAZIDE-RESERPINE | chlorothiazide; reserpine | TABLET;ORAL | 087745-001 | May 6, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
